Inovalon Holdings Inc (NASDAQ:INOV) – Stock analysts at KeyCorp upped their Q3 2018 earnings estimates for Inovalon in a report issued on Monday. KeyCorp analyst D. Hooker now anticipates that the technology company will post earnings per share of $0.12 for the quarter, up from their prior forecast of $0.11. KeyCorp also issued estimates for Inovalon’s Q4 2018 earnings at $0.12 EPS.
Inovalon (NASDAQ:INOV) last issued its quarterly earnings results on Tuesday, February 20th. The technology company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.01). Inovalon had a net margin of 7.51% and a return on equity of 4.79%. The firm had revenue of $114.60 million for the quarter, compared to analyst estimates of $116.83 million. During the same quarter last year, the business posted $0.05 earnings per share. The firm’s revenue for the quarter was up 19.3% compared to the same quarter last year.
Inovalon (NASDAQ:INOV) opened at $11.90 on Wednesday. Inovalon has a 1 year low of $10.99 and a 1 year high of $17.80. The stock has a market capitalization of $1,725.60, a price-to-earnings ratio of 49.59, a PEG ratio of 3.41 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a quick ratio of 4.82 and a current ratio of 4.82.
In other news, insider Shauna L. Vernal sold 44,270 shares of the firm’s stock in a transaction on Tuesday, January 23rd. The stock was sold at an average price of $14.00, for a total value of $619,780.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 48.28% of the company’s stock.
Several institutional investors have recently modified their holdings of the company. MetLife Investment Advisors LLC acquired a new stake in shares of Inovalon in the fourth quarter worth $450,000. Macquarie Group Ltd. boosted its position in shares of Inovalon by 877.8% in the fourth quarter. Macquarie Group Ltd. now owns 26,400 shares of the technology company’s stock worth $396,000 after buying an additional 23,700 shares during the period. Two Sigma Investments LP boosted its position in shares of Inovalon by 359.7% in the fourth quarter. Two Sigma Investments LP now owns 88,142 shares of the technology company’s stock worth $1,322,000 after buying an additional 68,967 shares during the period. Two Sigma Advisers LP boosted its position in shares of Inovalon by 248.9% in the fourth quarter. Two Sigma Advisers LP now owns 104,437 shares of the technology company’s stock worth $1,567,000 after buying an additional 74,500 shares during the period. Finally, Deutsche Bank AG boosted its position in shares of Inovalon by 187.8% in the fourth quarter. Deutsche Bank AG now owns 244,503 shares of the technology company’s stock worth $3,666,000 after buying an additional 159,534 shares during the period. 27.92% of the stock is owned by institutional investors and hedge funds.
Inovalon Company Profile
Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.
Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with MarketBeat.com's FREE daily email newsletter.